Lou, Z., Wang, X., Hu, C., Liu, W. and Ji, Y. (2024) “Combination of anlotinib and second-line chemotherapy as surrogate to reduce immunosuppression in patients with advanced non-small cell lung cancer”, Pakistan Journal of Medical Sciences, 40(7). doi: 10.12669/pjms.40.7.9681.